With Promise of Legalization, Psychedelic Companies Joust Over Future Profits

Cash rich start-ups are filing scores of patent claims on hallucinogens like magic mushrooms. Researchers and patient advocates worry high prices will make the therapies unaffordable.
NYT > Health